期刊文献+

胃癌患者胃液中5-羟色胺含量的检测及临床意义 被引量:1

EXAMINATION OF 5-HT IN GASTRIC JUICE OF GASTRIC CANCER PATIENTS AND ITS SIGNIFICANCE
下载PDF
导出
摘要 本文应用高效液相色谱与荧光分光光度计联机法检测55例胃液内5-羟色胺的含量,共分为正常、溃疡病、萎缩性胃炎、胃癌等4个组。其结果正常组含量为48.70±49.3ng/ml,溃疡病组含量为76.26±127.06ng/ml,慢性萎缩性胃炎组含量为197.29±128.4ng/ml,胃癌组含量为191.80±124.2ng/ml。4组之间进行对比分析,正常组和溃疡病组之间差异不明显(P>0.05),而萎缩性胃炎和胃癌两组与前两组之间差异均显著(P<0.01),但萎缩性胃炎和胃癌之间未见差异(P>0.05)。这充分证明5-羟色胺(5-HT)在萎缩性胃炎和胃癌的胃液中含量是很高的。对于胃癌和慢性萎缩性胃炎的诊断及与其它慢性胃病的鉴别诊断中可能起到很重要的作用。 The content of 5-HT in the gastric juice of 55 patients with gastric diseases was examined with highly effective liquid chromatography combined with fluoro-spectrophotometer. The results showed that the content of 5-HT was 48.70±49.30 ng/ml in the control group, 76.26±127.06ng/rnl in the gastroduodenal ulcer group, 191.80 ±124.80ng/ml in the stomach cancer group, and 197.29 ±128.4ng/ml in the atrophic gastritis group.No significant difference was found between the normal and the gastroduodenal ulcer groups (P>0.05) .Values of the cancer and the atrophic gastritis groups were outstanding among these 4 groups, with a marked significant difference (P<0. 01) .The authors think that these results are of considerable significance in early diagnosis of gastric carcinoma and chronic atrophic gastritis.
出处 《白求恩医科大学学报》 CSCD 1990年第4期376-378,共3页 Journal of Norman Bethune University of Medical Science
关键词 胃癌 胃液 5-羟色胺 诊断 Carcinoma of the stomach Gastric juice 5-hydroxytryptamine (5-HT)
  • 相关文献

参考文献1

  • 1团体著者,生理学,1978年

同被引文献37

  • 1方艺,于燕妮,胡军.胃泌素和5-羟色胺的表达与胃癌临床分期及分化程度的相关性研究[J].中国医师进修杂志,2006,29(10):4-5. 被引量:3
  • 2Fava M, Kendler KS. Major depressive disorder [J]. Neuron, 2000,28(2) :335-341.
  • 3Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system [J]. Pharmacol Rep, 2009,61 (5) :761-777.
  • 4Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineursj J], Neurology, 2005,65(4) :620.Q22.
  • 5Clada P, Puig M, Amarg6s-Bosch M, et al. The therapeutic role of 5-HTIA and 5-HT2A receptors in depression [J]. J Psychiatr Neurosci, 2004 ,29( 4) :252-265.
  • 6Dueottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor! antagonist antalarmin in the chronic mild stress model of depression in mice[J].Prog Neuropsychopharmacol BioI Psychiatry, 2003,27 ( 4) : 625 .Q31.
  • 7Brea J, Castro-Palomino J, Yeste S, et al. Emerging opportunities and concern for drug discovery at serotonin 5-HT2B receptors [J]. Curr Top Med Chern, 2010,10(5) :493-503.
  • 8Gomez-Merino 0, Bequet F, Berthelot M, et al. Evidence that the branched-chain amino acid L-valine prevents exercise-induced release of,5-HT in rat hippocampus [J]. Int J Sports Med, 2001,22 (5) :317-322.
  • 9Nelson JC, Portera L, Leon AC. Are there differences in the symptoms that respond to a selective 5-hydroxytryptamine or norepinephrine reuptake inhibitor [J]. Bid Psychiatry, 2005, 57 ( 12 ) : 1535-1542.
  • 10Borman RA, Tilford NS, Harmer OW, et al. 5-HT(2B)receptors play a key role in mediating the excitatory effects of 5 - HT in human colon in vitro [J]. Br J Pharmacol, 2002,135 (5) : 1144-1151.

引证文献1

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部